Diadema Partners LP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Diadema Partners LP
- $391 Billion
- Q3 2025
A detailed history of Diadema Partners LP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 2,506,921 shares of RVPH stock, worth $1.25 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,506,921
Previous 2,735,457
8.35%
Holding current value
$1.25 Million
Previous $1.04 Billion
11.36%
% of portfolio
0.24%
Previous 0.32%
Shares
3 transactions
Others Institutions Holding RVPH
# of Institutions
48Shares Held
12.1MCall Options Held
620KPut Options Held
31.4K-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$279,6210.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA524KShares$262,0250.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...